Literature DB >> 18411193

On the relevance of defining protein structures in cancer research.

Inés G Muñoz1, Franciso J Blanco, Guillermo Montoya.   

Abstract

Are three-dimensional structures of proteins relevant in the study of cancer? The knowledge of the three-dimensional structure of a protein is crucial to gain a full understanding of its function, and structural determination has already shown its potential for guided drug design. The knowledge of the structures of proteins and their complexes with other biological macromolecules helps to elucidate functional networks and provide a better understanding of the functionally relevant behaviour of the molecular machinery of the cell. To study the cell, we must be able to work with proteins, to elucidate how they diffuse and move, to know their interacting partners, and to understand the changes induced by those interactions. Three-dimensional structures give us a picture of the protein and thereby the opportunity to introduce mutations that alter its affinity and specificity for other interactions helping us to understand the physico-chemical mechanisms that control their function. In turn these can lead to the development of novel therapies.

Entities:  

Mesh:

Year:  2008        PMID: 18411193     DOI: 10.1007/s12094-008-0183-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  77 in total

Review 1.  Molecular dynamics simulations of biomolecules.

Authors:  Martin Karplus; J Andrew McCammon
Journal:  Nat Struct Biol       Date:  2002-09

2.  NMR indicates that the small molecule RITA does not block p53-MDM2 binding in vitro.

Authors:  Marcin Krajewski; Przemyslaw Ozdowy; Loyola D'Silva; Ulli Rothweiler; Tad A Holak
Journal:  Nat Med       Date:  2005-11       Impact factor: 53.440

3.  Phase I and pharmacologic study of PKI166, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies.

Authors:  Ronald Hoekstra; Herlinde Dumez; Ferry A L M Eskens; Ate van der Gaast; Andre S T Planting; Gerda de Heus; Kurt C Sizer; Christina Ravera; Sujata Vaidyanathan; Corazon Bucana; Isaiah J Fidler; Allan T van Oosterom; Jaap Verweij
Journal:  Clin Cancer Res       Date:  2005-10-01       Impact factor: 12.531

Review 4.  Strategies for optimizing combinations of molecularly targeted anticancer agents.

Authors:  Janet E Dancey; Helen X Chen
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

5.  Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the Avastin Fab.

Authors:  Germaine Fuh; Ping Wu; Wei-Ching Liang; Mark Ultsch; Chingwei V Lee; Barbara Moffat; Christian Wiesmann
Journal:  J Biol Chem       Date:  2005-12-22       Impact factor: 5.157

6.  Functional organization of the yeast proteome by systematic analysis of protein complexes.

Authors:  Anne-Claude Gavin; Markus Bösche; Roland Krause; Paola Grandi; Martina Marzioch; Andreas Bauer; Jörg Schultz; Jens M Rick; Anne-Marie Michon; Cristina-Maria Cruciat; Marita Remor; Christian Höfert; Malgorzata Schelder; Miro Brajenovic; Heinz Ruffner; Alejandro Merino; Karin Klein; Manuela Hudak; David Dickson; Tatjana Rudi; Volker Gnau; Angela Bauch; Sonja Bastuck; Bettina Huhse; Christina Leutwein; Marie-Anne Heurtier; Richard R Copley; Angela Edelmann; Erich Querfurth; Vladimir Rybin; Gerard Drewes; Manfred Raida; Tewis Bouwmeester; Peer Bork; Bertrand Seraphin; Bernhard Kuster; Gitte Neubauer; Giulio Superti-Furga
Journal:  Nature       Date:  2002-01-10       Impact factor: 49.962

7.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

8.  Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only.

Authors:  Sandra L Giannini; Emmanuel Hanon; Philippe Moris; Marcelle Van Mechelen; Sandra Morel; Francis Dessy; Marc A Fourneau; Brigitte Colau; Joann Suzich; Genevieve Losonksy; Marie-Thérèse Martin; Gary Dubin; Martine A Wettendorff
Journal:  Vaccine       Date:  2006-06-19       Impact factor: 3.641

9.  Backbone assignment of human proliferating cell nuclear antigen.

Authors:  Ricardo Sánchez; Daniel Torres; Jesús Prieto; Francisco J Blanco; Ramón Campos-Olivas
Journal:  Biomol NMR Assign       Date:  2007-11-30       Impact factor: 0.746

10.  Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus.

Authors:  N D Christensen; C A Reed; N M Cladel; R Han; J W Kreider
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.